Your browser doesn't support javascript.
loading
Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade.
Quetglas, José I; Labiano, Sara; Aznar, M Ángela; Bolaños, Elixabet; Azpilikueta, Arantza; Rodriguez, Inmaculada; Casales, Erkuden; Sánchez-Paulete, Alfonso R; Segura, Víctor; Smerdou, Cristian; Melero, Ignacio.
Afiliação
  • Quetglas JI; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain. imelero@unav.es jquetglas@unav.es.
  • Labiano S; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Aznar MÁ; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Bolaños E; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Azpilikueta A; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Rodriguez I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Casales E; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Sánchez-Paulete AR; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Segura V; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Smerdou C; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain.
  • Melero I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra, Pamplona, Navarra, Spain. imelero@unav.es jquetglas@unav.es.
Cancer Immunol Res ; 3(5): 449-54, 2015 May.
Article em En | MEDLINE | ID: mdl-25691326
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Floresta de Semliki / Interleucina-12 / Terapia Viral Oncolítica / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Floresta de Semliki / Interleucina-12 / Terapia Viral Oncolítica / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article